Journal
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 24, Issue 9, Pages 479-485Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/S0165-6147(03)00229-3
Keywords
-
Categories
Ask authors/readers for more resources
The discovery of the second estrogen receptor (ER) in 1995 surprised many endocrinologists and resulted in some scepticism regarding its physiological importance. However, 8 years later, it is clear that the multiple actions of estrogen in the body are mediated by two receptors that, although similar, are distinct gene products with non-overlapping functions. This clear delineation of the functions of the two receptors in such a short time was made possible by the development of ERalpha and ERbeta knockout mice. The distinct patterns of tissue distribution of these two receptors has heightened interest in novel estrogen targets in the body and has led to awareness of new sites for pharmacological intervention in diseases such as depression, prostate dysfunction, leukaemia, inflammatory bowel disease and colon cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available